Quantcast

Beacon Equity Research Clients

Below you will find a list of Beacon Equity Research's clients.
Click on the client's name to view information on that specific client.

QualityStocks Partner Clients

SmallCapVoice Clients
Stock Guru Clients

 


Untitled Document

Proteonomix, Inc. (PROT)

Proteonomix, Inc. (PROT) a biotechnology company, is engaged in the development of therapeutics based upon the use of human cells and their derivatives, particularly in the areas of diabetes and cardiac diseases. The Proteonomix Family of companies includes Proteoderm, StromaCel, National Stem Cell, PRTMI and THOR Biopharma.

Proteoderm, Inc. is a wholly owned subsidiary that has developed an anti-aging line of skin care products. StromaCel, Inc. develops therapeutic modalities for the treatment of Cardiovascular Disease (CVD). National Stem Cell, Inc. is Proteonomix's operating subsidiary. Proteonomix Regenerative Translational Medicine Institute, Inc. ("PRTMI") intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine.

Proteonomix aims to achieve a leadership position in life enhancement regenerative stem cell therapies, services, and products through a combination of first to market technologies and innovative clinical trial strategies.

Beacon Equity Research Blog

Proteonomix, Inc. Message Board

 

The QualityStocks
Newsroom

Read the articles covering the biggest movers in the markets today.

Continue

Market
Basics

Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks markets.

Continue

The QualityStocks Daily
Archives

Go back to see our previous newsletters and find out what you might have missed.

Continue